Skip to main content

Advertisement

SpringerLink
Log in

In Reply: Sentinel Lymph Node Biopsy in Melanoma

  • Melanomas
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Medalie N, Ackerman AB. Sentinel node biopsy has no benefit for patients whose primary cutaneous melanoma has metastasized to a lymph node and therefore should be abandoned now. Br J Dermatol. 2004;151:298–307.

    Article  CAS  PubMed  Google Scholar 

  2. Medalie NS, Ackerman AB. Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma metastatic to a lymph node: an assertion based on comprehensive, critical analysis: part II. Am J Dermatopathol. 2003;25:473–84.

    Article  PubMed  Google Scholar 

  3. Morton DL, Cochran AJ. The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma. Br J Dermatol. 2004;151:308–19.

    Article  CAS  PubMed  Google Scholar 

  4. Thomas JM, Patocskai EJ. The argument against sentinel node biopsy for malignant melanoma. BMJ. 2000;321:3–4.

    Article  CAS  PubMed  Google Scholar 

  5. Thomas JM, Clark MA. Sentinel lymph node biopsy: not yet standard of care for melanoma. BMJ. 2004;329:170–1.

    Article  PubMed  Google Scholar 

  6. Cochran AJ, Morton DL, Stern S, Lana AM, Essner R, Wen DR. Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment. Mod Pathol. 2001;14:604–8.

    Article  CAS  PubMed  Google Scholar 

  7. Cochran AJ, Huang RR, Lee J, Itakura E, Leong SP, Essner R. Tumour-induced immune modulation of sentinel lymph nodes. Nat Rev Immunol. 2006;6:659–70.

    Article  CAS  PubMed  Google Scholar 

  8. Black WC. Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening. J Natl Cancer Inst. 2000;92:1280–2.

    Article  CAS  PubMed  Google Scholar 

  9. Duffy SW, Nagtegaal ID, Wallis M, Cafferty FH, Houssami N, Warwick J, et al. Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival. Am J Epidemiol. 2008;168:98–104.

    Article  PubMed  Google Scholar 

  10. Jacques PF, Hartz SC, Tuthill RW, Hollingsworth C. Elimination of “lead time” bias in assessing the effect of early breast cancer diagnosis. Am J Epidemiol. 1981;113:93–7.

    CAS  PubMed  Google Scholar 

  11. Kafadar K, Prorok PC. A data-analytic approach for estimating lead time and screening benefit based on survival curves in randomized cancer screening trials. Stat Med. 1994;13:569–86.

    Article  CAS  PubMed  Google Scholar 

  12. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307–17.

    Article  CAS  PubMed  Google Scholar 

  13. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635–48.

    CAS  PubMed  Google Scholar 

  14. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–206.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Dermato-Oncology, Department of Dermatology, Eberhard-Karls-University, Tuebingen, Germany

    Ulrike Leiter MD & Claus Garbe MD

  2. Skin Cancer Research Group, North Queensland Centre for Cancer Research, School of Public Health, Tropical Medicine, and Rehabilitation Sciences, James Cook University, Townsville, QLD, Australia

    Claus Garbe MD

Authors
  1. Ulrike Leiter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claus Garbe MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claus Garbe MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leiter, U., Garbe, C. In Reply: Sentinel Lymph Node Biopsy in Melanoma. Ann Surg Oncol 18, 598–599 (2011). https://doi.org/10.1245/s10434-010-1068-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1068-2

Keywords

Search

Navigation